Arnall Golden Gregory is the presenting sponsor of Global Atlanta's Germany Channel. Subscribe here for monthly Germany newsletters.
Boehringer-Ingelheim, a German pharmaceuticals firm with a focus on both animal and human health, is investing $57 million to expand its Athens facility.
Boehringer-Ingelheim Animal Health USA Inc. was formed in 2019 when the German company acquired Merial, a French firm that had operated in Athens since 1989.
After the all-stock deal that closed the merger, the combined company announced it would invest $120 million and hire 225 more people in Georgia, including 75 at its Duluth headquarters, 100 at its manufacturing and R&D hub in Athens and 50 at its poultry site in Gainesville.
Another 55 jobs will accompany the Athens expansion announced April 20, which state officials said would more than double the company’s current footprint there.
Construction has already begun on a 63,000-square-foot facility that will connect two other office and lab buildings, and the company is also undertaking a 5,000-square-foot expansion and renovation of an existing innovation space.
Upon completion in 2024, the site will span 115,000 square feet and should enable closer collaboration between teammates coming back into the office after a period of separation during the COVID-19 pandemic, said Caroline Belmont, U.S. head of global innovation for Boehringer-Ingelheim, in a news release.
The new spaces will feature floor-to-ceiling windows bringing more natural light into the building, an atrium built for collaboration and an courtyard with multiple seating options and Wi-Fi to encourage outdoor meetings.
“The significant investment in expanding and enhancing our Athens Global Innovation site will provide not only a comfortable and flexible physical space that inspires collaboration, but also will bring many new tools and technologies to spark the innovation that will ultimately help improve animal and human wellbeing,” Ms. Belmont said.
Boehringer-Ingelheim Animal Health offers vaccines, parasiticides, therapeutics and digital health tools to customers in 150 countries.
The company, based in the German city of Ingelheim in the state of Rhineland-Palatinate, employs more than 1,200 people across its three facilities in Georgia, including 500 at the Duluth headquarters.
See Georgia jobs available here by searching “Georgia” in the location field.
Learn more here.
The Pendleton Group is the presenting sponsor of Global Atlanta's Economic Development Channel. Subscribe here for monthly Economic Development newsletters.
